La cadena de opciones muestra datos clave de las opciones de acciones de Roadzen a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Roadzen..

Roadzen (NASDAQ:RDZN) Bolsa, Cadena de Opciones

Roadzen

Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.

Roadzen Inc

News

Guidance

OSCR

Oscar Health Affirms FY2025 Sales Guidance of $11.20B-$11.30B vs $11.18B Est

Earnings

Earnings Beats

Earnings Misses

CORRECTION: BeiGene Q1 Adj. EPADS $1.22 Beats $(0.74) Estimate, Sales $1.12B Miss $1.14B Estimate

LifeStance Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFST#NASDAQ">LFST</a>) sees Q2 sales of $332.000 million-$352.000 million vs $352.76 million analyst estimate.

LFST

LifeStance Health Gr Sees Q2 Sales $332.000M-$352.000M vs $352.76M Est

Oscar Health Q1 EPS $0.92 Beats $0.83 Estimate, Sales $3.05B Beat $2.86B Estimate

LifeStance Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFST#NASDAQ">LFST</a>) affirms FY2025 sales outlook from $1.40 billion-$1.44 billion to $1.40 billion-$1.44 billion vs $1.42 billion estimate.

LifeStance Health Gr Affirms FY2025 Sales Guidance of $1.40B-$1.44B vs $1.42B Est

Walker & Dunlop Announced The Launch Of WDSuite, Its New Digital Experience Designed To Reduce Friction For Commercial Real Estate Professionals Throughout The Investment Lifecycle

AXTA

Axalta Coating Systems Affirms FY2025 Adj EPS Guidance of $2.50-$2.60 vs $2.48 Est; Lowers FY2025 Sales Guidance from $5.35B-$5.40B to $5.30B-$5.38B vs $5.34B Est

Fortis (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FTS#TSX">FTS</a>) reported quarterly earnings of $1.00 per share which beat the analyst consensus estimate of $0.95 by 5.26 percent. This is a 7.53 percent increase over earnings of $0.93 per share from the same period last year. The company reported quarterly sales of $3.34 billion which beat the analyst consensus estimate of $3.31 billion by 0.88 percent. This is a 7.06 percent increase over sales of $3.12 billion the same period last year.

TSX:FTS

Fortis Q1 EPS C$1.00 Beats C$0.95 Estimate, Sales C$3.34B Beat C$3.31B Estimate

LifeStance Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFST#NASDAQ">LFST</a>) reported quarterly sales of $332.97 million which beat the analyst consensus estimate of $332.90 million by 0.02 percent. This is a 10.83 percent increase over sales of $300.44 million the same period last year.

LifeStance Health Gr Q1 Sales $332.97M Beat $332.90M Estimate

Dividends

ACRE

Ares Commercial Declared A Regular Cash Dividend Of $0.15 Per Common Share For q2; Dividend Will Be Payable On July 15

Axalta Coating Systems Sees Q2 2025 Adj EPS $0.60-$0.63 vs $0.65 Est, Forecasts Q2 Net Sales YoY Growth In Low Single Digit Percentage

GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) raises FY2025 GAAP EPS guidance from $0.74-$0.88 to $0.77-$0.89 vs $1.22 analyst estimate..

GEO Group Raises FY2025 GAAP EPS Guidance from $0.74-$0.88 to $0.77-$0.89 vs $1.22 Est

GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) raises FY2025 sales outlook from $2.50 billion to $2.53 billion vs $2.66 billion estimate.

GEO Group Raises FY2025 Sales Guidance from $2.50B to $2.53B vs $2.66B Est

Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.08 by 62.5 percent. This is a 120.97 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $14.95 million which beat the analyst consensus estimate of $13.70 million by 9.11 percent. This is a 20.03 percent decrease over sales of $18.69 million the same period last year.

Ares Comml Real Est Q1 Adj. EPS $0.13 Beats $0.08 Estimate, Sales $14.95M Beat $13.70M Estimate

<ul>
<li>Outlook(5)</li>
</ul>
Taking into account first quarter results, the current margin and macro environment and forward curves, we continue to forecast full-year 2025 adjusted EPS of approximately $7.75. This forecast excludes the impact of announced acquisitions and divestitures that are expected to close during the year.
In Agribusiness, full-year results are forecasted to be slightly lower than our previous outlook and down from last year primarily due to lower results in Processing.
In Refined and Specialty Oils, full-year results are expected to be similar to our previous outlook and down from the prior year primarily driven by a more balanced supply and demand environment in North America.
In Milling, full-year results are expected to be similar to our previous outlook and up from last year.
In Corporate and Other, full-year results are expected to be more favorable than our previous outlook and the prior year.
Additionally, the Company expects the following for 2025: an adjusted annual effective tax rate in the range of 21% to 25%; net interest expense in the range of $220 to $250 million, which is down from our previous expected range of $250 to $280 million; capital expenditures in the range of $1.5 to $1.7 billion; and depreciation and amortization of approximately $490 million.

Bunge Global Maintains Its 2025 Adjusted EPS Forecast At Around $7.75,  Vs $7.79 Est.; Excluding Upcoming Acquisitions And Divestitures

Marcus &amp; Millichap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMI#NYSE">MMI</a>) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 57.69 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $145.04 million which beat the analyst consensus estimate of $140.20 million by 3.45 percent. This is a 12.34 percent increase over sales of $129.10 million the same period last year.

Marcus & Millichap Q1 EPS $(0.11) Beats $(0.16) Estimate, Sales $145.04M Beat $140.20M Estimate

GEO Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.18 by 22.22 percent. This is a 22.22 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $604.65 million which missed the analyst consensus estimate of $611.81 million by 1.17 percent. This is a 0.17 percent decrease over sales of $605.67 million the same period last year.

GEO Group Q1 Adj. EPS $0.14 Misses $0.18 Estimate, Sales $604.65M Miss $611.81M Estimate

Modiv Industrial Q1 2025 FFO $0.33 Beats $0.32 Estimate, Sales $11.73M Miss $11.75M Estimate

Entegris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) is looking for Q2 GAAP EPS of $0.34-$0.41 vs $0.47 analyst estimate..

ENTG

Entegris Sees Q2 GAAP EPS $0.34-$0.41 vs $0.47 Est

BeiGene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONC#NASDAQ">ONC</a>) affirms FY2025 sales outlook from $4.90 billion-$5.30 billion to $4.90 billion-$5.30 billion vs $36.54 billion estimate.

BeiGene Affirms FY2025 Sales Guidance of $4.90B-$5.30B vs $36.54B Est

Press Releases

Roadzen Inc. Announces Closing of Public Offering

General

Roadzen Adds DeepSeek R1 to Mixtape, Delivering Advanced Reasoning and Data Sovereignty for Insurance and Mobility AI Agents

Financing

Roadzen Strengthens Balance Sheet, Eliminates $5.5 Million in Short-Term Liabilities By Paying $1.65 million in Cash

Roadzen Reports Fiscal Third Quarter and First Nine-Months FY2025 Financial Results

Roadzen's MixtapeAI Wins 'Best AI in Deep Tech' at the Entrepreneur AI Awards 2025

Legal

Roadzen's DrivebuddyAI Awarded Patent for AI-Driven Driver Risk Assessment, Transforming Global Road Safety

Contracts

Roadzen Selected by India's Largest General Insurance Company to Manage its Roadside Assistance Program for a Second Consecutive Multi-Year Term

Roadzen Set to Benefit from India's New Road Safety Regulations

Roadzen Inc. Files Multi-Million Dollar Lawsuit Against Meteora for Breach of Contract to the Terms of the Forward Purchase Agreement

Roadzen Partners with One of the World's Largest Telematics Providers to Launch Connected Vehicle Protection in the UK

RDZN

ACCESS Newswire

XIAO-I Corporation - American Depositary Shares

XIAO-I

Aware

BeLive Hldgs

Cheetah Mobile Inc. American Depositary Shares, each representing fifty (50) Class A Ordinary Shares

Comments

Roadzen

Roadzen (RDZN) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL